Eli Lilly Shares New Obesity Drug Trial Data
Eli Lilly released new clinical trial data showing its obesity treatments helped patients achieve significant weight loss and lower blood sugar levels. The findings from studies on adults and adolescents were presented at a medical conference.
Xurve View
Insights:
Xurve View
Eli Lilly & Co released new clinical trial data showing its obesity drugs drove weight loss of up to 23.3% in adults and adolescents. The findings were presented on a Saturday during the ObesityWeek 2026 medical conference. Investors are weighing the commercial potential as the drugmaker expands its pipeline into younger cohorts.
